by University of Barcelona Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital Clínic and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) have identified a group of genetic variants related to the starting point of Parkinson’s disease. These results, published in the journal Movement Disorders, will enable delimiting the research on new therapeutic targets, and...
Tag: <span>Parkinson’s disease</span>
Post
Scientists listed ways of applying genetic engineering to treat Parkinson’s disease
How CRISPR can help fight against neurodegenerative diseases SECHENOV UNIVERSITY Researchers of Sechenov University and University of Pittsburgh described the most promising strategies in applying genetic engineering for studying and treating Parkinson’s disease. This method can help evaluate the role of various cellular processes in pathology progression, develop new drugs and therapies, and estimate their...
Post
Parkinson’s disease study identifies possible new treatment target
by Ziba Kashef, Yale University Treatments for Parkinson’s disease have most recently focused on increasing dopamine, a chemical messenger in the brain that affects reward-based behaviors and motivation, as well as movement. A new study by Yale researchers challenges long-held assumptions about dopamine’s sole role in this disorder. In people with Parkinson’s disease, nerve cells that produce dopamine slowly die. The loss...
Post
D-mine Pump for Continuous Delivery of Parkinson’s Meds
JULY 9TH, 2019 MEDGADGET EDITORS MEDICINE, NEUROLOGY EVER Pharma, based in Austria, won CE Mark approval and is releasing its D-mine Pump in Europe. Designed to deliver apomorphine hydrochloride, a dopamine agonist medication used to treat Parkinson’s, it has a few features that are tailored for the patients that it is intended to treat. Apomorphine hydrochloride helps many...
Post
New findings can help Parkinson’s patients
Posted Today This news or article is intended for readers with certain scientific or professional knowledge in the field. For patients with Parkinson’s disease, early signs of a certain part of the brain being broken down has been shown to have a negative impact on the course of the disease. The results of a study which researchers from...
Post
New brain imaging study reveals signs of Parkinson’s decades before symptoms appear
Rich Haridy A new study from King’s College London upends conventional thinking about the origins of Parkinson’s disease in the brain. The research reveals distinct changes in the brain’s serotonin system can be identified up to 20 years before any Parkinson’s symptoms appear, suggesting a new biomarker to detect the disease at its earliest stages....
Post
How ultrasound could help curb Parkinson’s
By Catharine Paddock PhD Fact checked by Carolyn Robertson There are two major stumbling blocks to developing effective drugs for Alzheimer’s, Parkinson’s, and other diseases that destroy the brain. The first is overcoming the blood-brain barrier, and the second is delivering the drug to a precise location and ensuring that it does not spread to...
Post
Device continuously monitors the symptoms of patients with Parkinson’s
by Universitat Politècnica de Catalunya Until now, the lack of precise, continuous data on the clinical status of individuals affected by Parkinson’s disease throughout the day was one of the main difficulties faced by neurologists in charge of adapting treatment. Now, this obstacle has been overcome with a new device called STAT-ON. It is a small sensor held in...
Post
Early life exposure to nicotine alters neurons, predisposes brain to addiction later
In mouse study, neonatal exposure changed biochemistry of reward circuitry; researchers suggest same mechanism may be at work in humans IMAGE: A STAINED MICROGRAPH OF A MOUSE PURKINJE NEURON, A TYPE OF BRAIN CELL THAT RELEASES THE GABA NEUROTRANSMITTER, AND WHICH IS AFFECTED BY NICOTINE EXPOSURE. CREDIT: CELL IMAGE LIBRARY, NCMIR Neonatal exposure to nicotine...
Post
More evidence that blood tests can detect the risk of Alzheimer’s
by Lund University A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein (NFL) in blood samples from patients with Alzheimer’s disease. Recently published in JAMA Neurology, the study suggests that the NFL concentration in the blood could be able to indicate if a drug actually affects the loss of...